Brenda Mann is VP of Research & Development of KIORA PHARMACEUTICALS INC. Currently has a direct ownership of 15,136 shares of KPRX, which is worth approximately $56,457. The most recent transaction as insider was on Nov 02, 2021, when has been sold 62 shares (Common Stock) at a price of $1.98 per share, resulting in proceeds of $123. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.1K
0% 3M change
0% 12M change
Total Value Held $56,457

Brenda Mann Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 02 2021
SELL
Payment of exercise price or tax liability
$123 $1.98 p/Share
62 Reduced 0.41%
15,136 Common Stock
Oct 04 2021
SELL
Payment of exercise price or tax liability
$125 $2.01 p/Share
62 Reduced 0.41%
15,198 Common Stock
Sep 02 2021
SELL
Payment of exercise price or tax liability
$110 $1.81 p/Share
61 Reduced 0.4%
15,260 Common Stock
Aug 03 2021
SELL
Payment of exercise price or tax liability
$151 $2.4 p/Share
63 Reduced 0.41%
15,321 Common Stock
Jul 02 2021
SELL
Payment of exercise price or tax liability
$570 $3.7 p/Share
154 Reduced 0.99%
15,384 Common Stock
Jun 04 2021
SELL
Payment of exercise price or tax liability
$649 $4.19 p/Share
155 Reduced 0.99%
15,538 Common Stock
May 04 2021
SELL
Payment of exercise price or tax liability
$789 $4.13 p/Share
191 Reduced 1.2%
15,693 Common Stock
Apr 08 2021
SELL
Payment of exercise price or tax liability
$948 $4.94 p/Share
192 Reduced 1.19%
15,884 Common Stock
Mar 03 2021
SELL
Payment of exercise price or tax liability
$1,048 $5.46 p/Share
192 Reduced 1.18%
16,076 Common Stock
Feb 02 2021
SELL
Payment of exercise price or tax liability
$6,264 $6.34 p/Share
988 Reduced 5.73%
16,268 Common Stock
Jan 04 2021
SELL
Payment of exercise price or tax liability
$558 $4.85 p/Share
115 Reduced 0.66%
17,256 Common Stock
Dec 07 2020
SELL
Payment of exercise price or tax liability
$342 $3.76 p/Share
91 Reduced 0.52%
17,371 Common Stock
Nov 02 2020
SELL
Payment of exercise price or tax liability
$337 $3.51 p/Share
96 Reduced 0.55%
17,462 Common Stock
Oct 02 2020
SELL
Payment of exercise price or tax liability
$380 $3.88 p/Share
98 Reduced 0.56%
17,558 Common Stock
BM

Brenda Mann

VP of Research & Development
Waltham, MA

Track Institutional and Insider Activities on KPRX

Follow KIORA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPRX shares.

Notify only if

Insider Trading

Get notified when an Kiora Pharmaceuticals Inc insider buys or sells KPRX shares.

Notify only if

News

Receive news related to KIORA PHARMACEUTICALS INC

Track Activities on KPRX